| 2022 | | Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities | 박해심 |
| 2024 | | Real-World Effectiveness of Statin Therapy in Adult Asthma | 박래웅, 박해심, 양형모, 이영수, 장재혁 |
| 2024 | | Real-world treatment trajectories of adults with newly diagnosed asthma or COPD | 박래웅, 박해심, 이영수 |
| 2021 | | Recent update on the management of anaphylaxis | 박해심, 장재혁 |
| 2023 | | Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis | 박해심 |
| 2021 | | Risk factors predicting Severe Asthma exacerbations in adult asthmatics: A real-world clinical evidence | 박해심, 신유섭, 예영민 |
| 2023 | | Role of club cell 16-kDa secretory protein in asthmatic airways | 박해심 |
| 2022 | | Role of Thymus and Activation-Regulated Chemokine in Allergic Asthma | 김승현, 박해심 |
| 2021 | | S100A9 in adult asthmatic patients: a biomarker for neutrophilic asthma | 박해심, 신유섭, 최영우 |
| 2019 | | Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis | 남동호, 박해심, 신유섭, 예영민, 이소희 |
| 2024 | | Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study | 박해심, 예영민 |
| 2022 | | Serum Amyloid A1: A Biomarker for Neutrophilic Airway Inflammation in Adult Asthmatic Patients | 박해심, 신유섭, 최영우 |
| 2021 | | Serum Human β-Defensin 2 Is Increased in Angioedema Accompanying Chronic Spontaneous Urticaria | 박해심, 예영민 |
| 2020 | | Serum potential biomarkers according to sputum inflammatory cell profiles in adult asthmatics | 박해심, 예영민 |
| 2021 | | Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | Specific antibody deficiency in adult patients with igg or igg subclass deficiency | 박해심, 장재혁 |
| 2021 | | Sputum antinuclear antibody serves as a biomarker for severe asthma | 박해심, 신유섭 |
| 2024 | | ST2-Mediated Neutrophilic Airway Inflammation: A Therapeutic Target for Patients With Uncontrolled Asthma | 박해심, 신유섭, 장재혁, 최영우 |
| 2021 | | The blocking effect of the glycoprotein IIb/IIIa receptor in the mouse model of asthma | 박해심, 신유섭 |
| 2022 | | The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea | 박해심, 예영민 |
| 2023 | | The effect of apigenin, an aryl hydrocarbon receptor antagonist, in Phthalate-Exacerbated eosinophilic asthma model | 박해심, 신유섭 |
| 2022 | | The Role of Di(2-Ethylhexyl) Phthalate as an Exacerbating Factor in Chronic Spontaneous Urticaria | 박해심, 신유섭 |
| 2023 | | Tissue Inhibitor of Metalloproteinase-1 Enhances Eosinophilic Airway Inflammation in Severe Asthma | 박해심, 신유섭, 유민숙, 최영우 |
| 2020 | | Toward personalization of asthma treatment according to trigger factors | 박해심 |
| 2019 | | Transforming growth factor-beta1 and eosinophil-derived neurotoxins contribute to the development of work-related respiratory symptoms in bakery workers | 박해심, 이소희 |
| 2021 | | Update on latex allergy: New insights into an old problem | 박해심 |
| 2020 | | Update on the Management of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity | 박해심 |
| 2021 | | Urine microbial extracellular vesicles can be potential and novel biomarkers for allergic diseases | 박해심, 최영우 |
| 2020 | | Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020 | 박해심 |
